About FDA
ORA Quality Audit Program
Description: As ORA continues to meet the demand for an increased number of inspections, its adherence to quality will be paramount in ensuring that work is done in a consistent and cost effective manner. The objective for this project is to implement an audit program, and begin internal audits using an audit check list that will provide ORA with information as to functionalities and uniformity of its Quality Management System (QMS). This audit cycle will cover all ORA units that are not already audited by 3rd party accreditation services. The audit cycle is three years long, and will cover all of ORA.
A. Initiate ORA Quality Audit Program
Briefing Status: On Hold
Prior Briefing Status: On Hold
| Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
|---|---|---|---|
|
1. Complete Audit Program Training with ORA QSMs |
11/15/2011 |
Completed | 11/15/2011 |
|
2. Complete Gap Analysis of Quality Management System in every ORA Quality Unit |
12/1/2011 |
Completed | 12/1/2011 |
|
3. Have 10 ORA QSMs Certified by American Society for Quality (ASQ) as Auditors |
12/15/2011 |
Completed | 12/15/2011 |
|
4. Complete Evaluation of Gap Analysis |
12/31/2011 |
Completed | 2/7/2012 |
|
5. Complete Schedule of ORA Quality Audits |
3/31/2012 |
Completed | 5/1/2012 |
|
6. Complete Scheduled ORA Quality Audits for FY 2012 |
9/31/2012 |
On Hold |
Key Projects Legend
| Milestone Status | Definition |
|---|---|
| Not Yet Started | Work for specific milestone has not yet been started. |
| Completed | Milestone and/or overall project is completed. |
| On Track | Milestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status. |
| On Hold | Milestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status. |
| Delayed | Milestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status. |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
